Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

State Of The Science At FDA: Catching Up With Jesse Goodman

This article was originally published in The Gray Sheet

Executive Summary

As the swine flu pandemic shows signs of leveling off, FDA Chief Scientist Jesse Goodman is ready to turn attention back to his original raison d'etre: improving the agency's scientific capacity and integrity
Advertisement

Related Content

FDA Eyes The Future: 2010 Workshop To Address Integration Of "New Science"
FDA Reorganization Elevates Scientific And Food Safety Priorities
First Showing Of New FDA Leadership Comes In Public Health Emergency
First Showing Of New FDA Leadership Comes In Public Health Emergency
FDA Scientific Capacity Inadequate; New Device Technology At Risk

Topics

Advertisement
UsernamePublicRestriction

Register

MT028340

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel